MEDICAL MARIJUANA

Medical Marijuana Shift Brings Big Stakes for the Midwest 0
- MEDICAL MARIJUANA
- May 6, 2026
The Trump administration’s decision to reclassify medical marijuana from Schedule I to Schedule III could quietly remake the Midwest cannabis landscape, even as prohibition holds firm in states like Wisconsin. The federal move leaves recreational marijuana untouched but opens the door for medical operators to access tax deductions, federal credits, and mainstream banking services that
READ MORE
Alabama Medical Marijuana Launch Delayed Five Years, Now Set for Early May 0
- MEDICAL MARIJUANA
- April 30, 2026
After nearly five years of legislative approval and extensive litigation, Alabama’s medical cannabis program is finally approaching launch. According to Alabama.com, the first biomass was delivered to processors on April 10, with dispensaries expected to open in early to mid-May. Alabama’s program prohibits smokable forms, restricting products to tablets, tinctures, patches, oils, and peach-flavored gummies. The
READ MORE
DOJ Reclassifies Medical Marijuana in ‘Historic’ Policy Shift 0
- MEDICAL MARIJUANA
- April 28, 2026
The U.S. Department of Justice has ordered looser federal regulation of state-legal medical marijuana, in what advocates are calling a “historic” shift in federal drug policy. Under an order signed by acting Attorney General Todd Blanche, many cannabis products will move from Schedule I, the government’s strictest drug category, to Schedule III, aligning them with
READ MORE

New Study Finds Medical Cannabis May Replace Opioids and Other Prescriptions 0

A new survey of more than 3,500 patients suggests medical cannabis could significantly reduce reliance on traditional prescription drugs, including opioids, sleeping aids and antidepressants. The study, conducted by German telehealth firm Bloomwell, found patients reduced their use of medications by an average of 84.5 percent after starting medical marijuana, with nearly 59 percent stopping

House Rejects Medical Marijuana Testing Bill, Leaving Future Oversight in Limbo 0

House Rejects Medical Marijuana Testing Bill, Leaving Future Oversight in Limbo Maine’s push to tighten oversight of its medical marijuana market has stalled after the House overwhelmingly rejected a key testing and tracking bill, LD 1847. The proposal, authored by Rep. Anne Graham, D-Newport, would have required batch testing and product tracking for medical cannabis,

Texas Adds Three Conditional Licensees as Medical Cannabis Program Grows 0

Texas Adds Three Conditional Licensees as Medical Cannabis Program Grows Texas is moving to expand its tightly regulated medical cannabis market, with three additional businesses advancing in the state licensing process. The Department of Public Safety (DPS) announced it has entered Phase II of the Texas Compassionate Use Program expansion, conditionally selecting GTI Texas LLC